+499.5%
MRNA vs MCO
+0.4%
+499.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MCO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.1% | -0.1% | -0.1% |
| 7D | +5.5% | -4.2% | +9.6% | +9.8% |
| 30D | +158.7% | +2.2% | +156.5% | +155.9% |
| 3M | +182.1% | +10.1% | +172.0% | +167.6% |
| 6M | +151.8% | +5.3% | +146.6% | +144.3% |
| YTD | +393.6% | -2.7% | +396.3% | +396.9% |
| 1Y | +499.5% | -0.4% | +499.9% | +490.4% |
| All | +499.5% | +0.4% | +499.1% | +490.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MCO.
Daily Out/Under-Performance
Portfolio return minus MCO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MCO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MCO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling